Check patentability & draft patents in minutes with Patsnap Eureka AI!

The preparation method of medetomidine

A technology of medetomidine and reaction, applied in the field of preparing medetomidine, can solve the problems of expensive, expensive to use, time-consuming and the like

Inactive Publication Date: 2016-03-02
LONZA LTD
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0009] Known methods for the preparation of medetomidine typically use protecting groups, such as trityl (trityl) residues, which cause high material consumption and require protection / deprotection steps
Therefore, these syntheses are time consuming and expensive
In addition, more expensive and non-ready starting materials are used

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • The preparation method of medetomidine
  • The preparation method of medetomidine
  • The preparation method of medetomidine

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0272] Example 1: 2-(2,3-Dimethylphenyl)propan-2-ol, compound of formula (XXIV), prepared via an organomagnesium intermediate

[0273] 1-Bromo-2,3-dimethylbenzene (compound of formula (XXV) wherein Q is Br; 8.43 g, 45.6 mmol) was dissolved in dry THF (15 mL) and placed in a dropping funnel. Separately, Mg filaments (1.10 g, 45.3 mmol) in dry THF (5 mL) were placed in a flask equipped with the above dropping funnel, stirrer and reflux condenser. 1-Bromo-2,3-dimethylbenzene solution (1.0 mL) was added via the dropping funnel, the reaction was started by adding 1,2-dibromoethane (3 drops), followed by the addition of the remaining 1-bromo-2, 3-Dimethylbenzene solution. Add the contents of the dropping funnel at a rate that maintains a small reflux. After the addition was complete, the mixture was refluxed for 1 hour and then cooled to 0°C. A solution of dry acetone (4.2 mL, 58 mmol) in dry THF (15 mL) was added dropwise and the mixture was stirred at 0 to 20 °C for 3 hours. T...

Embodiment 2

[0277] Example 2: 2-(2,3-Dimethylphenyl)propan-2-ol, compound of formula (XXIV), prepared via an organolithium intermediate

[0278] 1-Bromo-2,3-dimethylbenzene (compound of formula (XXV) where Q is Br; 4.25 g, 23.0 mmol) was dissolved in dry THF (15 mL) in a flask equipped with a thermometer and stir bar . The mixture was cooled to -78°C. n-Butyllithium (1.6M in hexane, 17.5 mL, 28.0 mmol) was added dropwise via syringe keeping the temperature below -70 °C. When the addition was complete, the mixture was kept at -78°C and stirred at this temperature for 1 hour. A solution of dry acetone (1.85 mL, 25.2 mmol) in dry THF (5 mL) was then added at -78 °C. The mixture was stirred at -78°C for 30 minutes, the cooling tank was removed and the mixture was allowed to reach room temperature. The mixture was poured into saturated NH 4 Cl aqueous solution (100mL), extracted with hexane (4 times, 50mL each time), passed through Na 2 SO 4 Drying and purification by silica gel column ...

Embodiment 3

[0280] Example 3: 1,2-Dimethyl-3-(2-propenyl)benzene, compound of formula (XXIII)

[0281] 2-(2,3-dimethylphenyl)propan-2-ol (compound of formula (XXIV), 1.10 g, 6.70 mmol) prepared according to Example 1 or Example 2 was dissolved in benzene (20 mL), And p-toluenesulfonic acid monohydrate (35 mg, 0.18 mmol) was added. The mixture was stirred at room temperature for 3 hours. Silica gel (200 mg) was added and stirring was continued for about 16 hours, then the reaction mixture was refluxed for 30 minutes. After cooling to room temperature, the mixture was filtered and washed with K 2 CO 3 Aqueous washing, conventional drying, and concentration under reduced pressure afforded 0.90 g (92%) of the title compound.

[0282] 1 HNMR:2.02(m,3H),2.21(s,3H),2.28(s,3H),4.82(m,1H),5.17(m,1H),6.97(m,1H),7.05(m,2H) .

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a method for the preparation of medetomidine starting from 1-bromo 2,3-dimethylbenzene and aceton.

Description

technical field [0001] The invention discloses a method for preparing medetomidine starting from 1-bromo-2,3-dimethylbenzene and acetone. Background technique [0002] Medetomidine is a compound of formula (XX), an alpha2 adrenergic agonist, currently used as a veterinary sedative and analgesic and is considered an anesthetic. [0003] [0004] Medetomidine is a 4-alkylimidazole. 4-Alkylimidazoles containing no other substituents at the nitrogen group are generally a mixture of two tautomers. For example, in the case of medetomidine, if medetomidine is dissolved or in a non-crystalline state, the two tautomeric forms (represented by the compound of formula (XX) and the compound of formula (XX-T)) are usually will change each other. Whether one of the tautomeric forms predominates or they exist in equal amounts depends on various factors such as pH, solvent or temperature. [0005] [0006] Herein, formula (XX) is used for medetomidine and is meant to include both t...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D233/58
CPCC07D233/58
Inventor 弗洛伦斯奥·萨拉戈萨道尔沃德安娜·库勒撒史蒂芬·埃琳娜罗伯特·布约克兹比格纽·沃贝克里斯托弗·沃伊切霍夫斯基
Owner LONZA LTD
Features
  • R&D
  • Intellectual Property
  • Life Sciences
  • Materials
  • Tech Scout
Why Patsnap Eureka
  • Unparalleled Data Quality
  • Higher Quality Content
  • 60% Fewer Hallucinations
Social media
Patsnap Eureka Blog
Learn More